The 3 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 20.00, with a high estimate of 27.00 and a low estimate of 19.00. The median estimate represents a +292.93% increase from the last price of 5.09.
The current consensus among 3 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.23
Reporting Date Mar 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.